Episurf Medical
1,19SEK -0,83%1 investor følger denne virksomhed
Episurf Medical is a medical technology company. The company conducts research and development of products used for the treatment of cartilage damage. Episurf's primary focus is on the recovery of knee joints, but the company's implants can also be applied to other joints. Episurf Medical is in the preclinical verification phase and is headquartered in Stockholm.
Omsætning
6,6 mio.
EBIT %
-1.166,67 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
EPIS B
Daglig lav / høj pris
1,18 / 1,26
SEK
Markedsværdi
317,24 mio. SEK
Aktieomsætning
581,64 t SEK
Volumen
479 t
Seneste videoer
Finanskalender
Årsrapport
09.02.2024
Generalforsamling
09.04.2024
Delårsrapport
24.04.2024
Delårsrapport
12.07.2024
Delårsrapport
25.10.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Health Runner | 13,0 % | 13,0 % |
| SEB AB, London Branch, W8IMY | 4,7 % | 4,7 % |
Premium
Not activated
This content is for our Premium customers only.
ViserAlle indholdstyper